Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Amgen Plugs Away On Repatha, With Hope For New Monthly Product

Executive Summary

In a very strong second-quarter earnings report, Amgen reports just $27m in worldwide sales for cholesterol-busting PCSK9 inhibitor Repatha, as reimbursement continues to present a big hurdle.

Advertisement

Related Content

Amgen’s Biggest Seller Enbrel Hit By Pricing Pressures, Competition
3Q Pharma Results Preview: Novartis, Merck, Lilly, Bayer, GSK, Bristol, Amgen, Sanofi
Amgen's Kyprolis Miss In First-Line Myeloma Surprising, But Clinically Irrelevant
Amgen Files Osteoporosis Drug In US Ahead Of Rival Merck
2Q Preview: GSK, Bayer, Celgene, Amgen, AZ, BMS, Sanofi, Merck, Abbvie
'Uncomfortable' Panel Backs Amgen Biosimilar, But Uphill Battle To Sway Docs, Public
Repatha Monthly Dose Approved With On-Body Pushtronex System
Amgen/Novartis CGRP Inhibitor Migraine Data Underwhelm Ahead Of Phase III Apex
Regeneron: PCSK9s Drowning In Paperwork
PCSK9 Sponsors, Payers In The Ring At ACC

Topics

Related Companies

Related Deals

Advertisement
UsernamePublicRestriction

Register

SC097002

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel